{
 "name": "杏輝",
 "slug": "tw-1734",
 "aliases": [
  "杏輝藥品工業股份有限公司",
  "SINPHAR",
  "1734"
 ],
 "ticker": "1734",
 "industry": "生技醫療業",
 "website": "www.sinphar.com",
 "summary": "杏輝（1734）是上市的生技醫療類股公司，1977 年成立，2002 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "杏輝藥品工業股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "SINPHAR",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2002-08-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "1977-07-02",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "李易達",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "白友烺",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 2016085810,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "國富浩華聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "www.sinphar.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 254433,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": -22.55,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 2.09,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "管線：ST01",
   "value": "失智症／腦部健康｜台灣及美國准予第二期；試驗執行準備中｜台灣、美國",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "植物新藥／天然植物原料；以年報當時狀態為準。"
  },
  {
   "claim": "管線：ST02",
   "value": "慢性穩定性心絞痛｜第二期階段性完成；後續開發規劃中｜台灣、美國",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "植物新藥；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SF01",
   "value": "癌症輔助用藥之研發｜臨床前成藥研究階段性完成｜未揭露藥物試驗地區",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "同一原料的健康食品認證，不等於癌症用藥上市許可；以年報當時狀態為準。"
  },
  {
   "claim": "管線：GF159",
   "value": "腦部健康之研究用途｜功效臨床實驗完成｜未揭露試驗地區",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "天然植物原料，非藥品Phase；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SB01",
   "value": "頭頸癌｜第二期試驗執行完畢；藥物療效與劑量方案研擬中｜台灣；美國獲准第二期",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥管線；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SB02",
   "value": "癌症治療｜臨床前製劑開發；處方最佳化方案研擬中｜未揭露試驗地區",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥管線；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SB03（酚瑞淨／VEREGEN）",
   "value": "生殖器疣｜台灣已取得藥證並銷售｜台灣",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥取得授權之產品；無完整首次日期不另建產品許可；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SB04",
   "value": "乾式老年性黃斑部病變｜台灣准予二／三期；劑量調整方案研擬中｜台灣；授權韓國AJU Pharm",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥管線；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SB05",
   "value": "三陰性乳癌｜獲准第三期；可行性方案研擬中｜比利時、台灣、澳洲",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥管線；以年報當時狀態為準。"
  },
  {
   "claim": "管線：SB05PC（EndoTAG-1）",
   "value": "胰臟癌｜美歐亞第三期期末分析完成後方案研擬中；另獲中國第三期許可｜美國、台灣、法國、匈牙利、南韓、俄羅斯、以色列、中國",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥管線；中國試驗不與七國既有試驗混同；以年報當時狀態為準。"
  },
  {
   "claim": "授權合作：SB03（VEREGEN；增修合約）",
   "value": "Medigene AG｜亞洲（不含中國大陸、韓國）、紐西蘭、澳洲｜2013-02-21",
   "unit": "",
   "as_of": "2026-05-12",
   "source": "https://www.sinphar.com/_upload/images/2606121325370.pdf",
   "note": "子公司杏國新藥之專屬授權；原文明載102/2/21「簽訂增修合約」，非把契約起日推定為簽約日。金額與權利金比率於本年報未公開。"
  },
  {
   "claim": "催化劑：藥品組合",
   "value": "高血脂、消化道及痤瘡治療等4品項規劃領證｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：功能性食品組合",
   "value": "規劃5項功能性食品上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：醫美保養品組合",
   "value": "規劃9項醫美保養品上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：產品M（泰國）",
   "value": "註冊中產品M預計上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：產品M（馬來西亞）",
   "value": "註冊中產品M預計上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：產品Y（馬來西亞）",
   "value": "註冊中產品Y預計上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：產品M（印尼）",
   "value": "註冊中產品M預計上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  },
  {
   "claim": "催化劑：產品Y（香港）",
   "value": "註冊中產品Y預計上市｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.sinphar.com/_upload/images/2609161728150.pdf",
   "note": "僅保留公司公開的年份；產品字母代號不得自行推定學名；上市／領證日期為公司規劃。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-23",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-1734.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}